Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

DelMar Pharmaceuticals commences phase I/II trial of VAL-083

Oct. 26, 2011

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Phase III trial of cabozantinib meets primary endpoint

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...